Diffuse alveolar hemorrhage following inhaled sevoflurane: A rare complication of inhalational anesthesia

BARAN KETENCİOĞLU B., HASTEKKEŞİN M., YETKİN N. A., TUTAR N.

TUBERKULOZ VE TORAKS, vol.71, no.4, pp.428-432, 2023 (ESCI) identifier identifier identifier identifier

  • Publication Type: Article / Case Report
  • Volume: 71 Issue: 4
  • Publication Date: 2023
  • Doi Number: 10.5578/tt.20239611
  • Journal Name: TUBERKULOZ VE TORAKS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, CAB Abstracts, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.428-432
  • Keywords: Diffuse alveolar hemorrhage, hemoptysis, inhaled anesthetics, inhaled sevoflurane
  • Erciyes University Affiliated: Yes

Abstract

Sevoflurane is a commonly used inhalational anesthetic agent for inducing and maintaining general anesthesia. However, it has been associated with a rare but serious pulmonary condition known as diffuse alveolar hemorrhage (DAH). DAH is characterized by decreased hemoglobin levels, diffuse pulmonary infiltration, and respiratory failure with hypoxemia. We present a case of DAH in a healthy young adult who experienced this condition following general anesthesia with inhaled sevoflurane during an uncomplicated orthopedic procedure. Notably, there were no other risk factors or known causes that could account for the development of DAH in this patient.